<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00867763</url>
  </required_header>
  <id_info>
    <org_study_id>2939</org_study_id>
    <nct_id>NCT00867763</nct_id>
  </id_info>
  <brief_title>In Vitro Maturation With in Vitro Fertilization (IVF) Compared to Mild in Vitro Fertilization</brief_title>
  <acronym>IVM vs IVF</acronym>
  <official_title>Clinical Research Study on in Vitro Maturation With IVF Compared to Mild Stimulation IVF</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Batzofin Fertility Services</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Batzofin Fertility Services</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Methods of infertility treatment may involve in vitro fertilization or IVF. Though effective,
      IVF is complex and expensive. Methods using no gonadotropin hormone stimulation of the
      ovaries are being compared to mild stimulation doses. The goal of the research is to
      determine which of these if more suitable as a low cost approach for varying individual
      patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Low cost environment is utilized, but fees are charged.
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    investigator changed location, requires new training effort
  </why_stopped>
  <start_date>March 2009</start_date>
  <completion_date type="Anticipated">June 2012</completion_date>
  <primary_completion_date type="Anticipated">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Health Services Research</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Cost effectiveness</measure>
    <time_frame>two years</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Ongoing pregnancy rates per cycle</measure>
    <time_frame>3 months</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">1440</enrollment>
  <condition>Infertility</condition>
  <arm_group>
    <arm_group_label>IVM</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Early egg retrieval, in vitro maturation, then IVF</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Mild IVF</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Mild gonadotropin and conventional IVF</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>In vitro maturation and in vitro fertilization</intervention_name>
    <description>No gonadotropin, eggs harvested early</description>
    <arm_group_label>IVM</arm_group_label>
    <other_name>assisted reproduction</other_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Low doses of gonadotropin stimulation.</intervention_name>
    <description>Gonadotropin followed by conventional IVF</description>
    <arm_group_label>Mild IVF</arm_group_label>
    <other_name>Assisted reproduction, IVF.</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Under age 42 female, normal uterine cavity, BMI 18-34kg/m2,

        Exclusion Criteria:

          -  Donor eggs, donor sperm, myoma over 5 cm

          -  Current hydrosalpinx, abnormal uterine cavity.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>41 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Joe B Massey, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Batzofin Fertility Services</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Batzofin Fertilty Services</name>
      <address>
        <city>New York</city>
        <state>New York</state>
        <zip>10016</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>BFS</name>
      <address>
        <city>NY</city>
        <state>New York</state>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Son WY, Chung JT, Herrero B, Dean N, Demirtas E, Holzer H, Elizur S, Chian RC, Tan SL. Selection of the optimal day for oocyte retrieval based on the diameter of the dominant follicle in hCG-primed in vitro maturation cycles. Hum Reprod. 2008 Dec;23(12):2680-5. doi: 10.1093/humrep/den332. Epub 2008 Sep 4.</citation>
    <PMID>18775885</PMID>
  </reference>
  <reference>
    <citation>Son WY, Chung JT, Demirtas E, Holzer H, Sylvestre C, Buckett W, Chian RC, Tan SL. Comparison of in-vitro maturation cycles with and without in-vivo matured oocytes retrieved. Reprod Biomed Online. 2008 Jul;17(1):59-67.</citation>
    <PMID>18616892</PMID>
  </reference>
  <verification_date>March 2009</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 23, 2009</study_first_submitted>
  <study_first_submitted_qc>March 23, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 24, 2009</study_first_posted>
  <last_update_submitted>August 10, 2010</last_update_submitted>
  <last_update_submitted_qc>August 10, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 11, 2010</last_update_posted>
  <responsible_party>
    <name_title>Joe B. Massey MD</name_title>
    <organization>Massey</organization>
  </responsible_party>
  <keyword>Polycystic ovaries,</keyword>
  <keyword>Tubal occlusion</keyword>
  <keyword>Unexplained infertility</keyword>
  <keyword>Low ovarian reserve</keyword>
  <keyword>Male factor infertility</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

